Chang Hyeon-Jun, Kim Yoon-Hee, Kang Yun-Hwan, Choi Myung-Hwan, Lee Jeung-Hee
Department of Food and Nutrition, Daegu University, Gyeonsan, 38453 Korea.
National Institute for Korean Medicine Development, Gyeonsan, 38540 Korea.
Food Sci Biotechnol. 2020 Aug 5;29(10):1413-1423. doi: 10.1007/s10068-020-00793-9. eCollection 2020 Oct.
Nine medicinal plants and their stick-type medicinal concentrated beverages (SMCB-I and SMCB-II) with different combination ratio were evaluated on antioxidant, nitric oxide (NO) inhibitory, and antibacterial effects against pathogenic bacteria involved in respiratory system illnesses. Antioxidant activity was high in , , , and which have higher contents of total phenolics and total flavonoids. The NO inhibitory activity was high in , , and . , and showed higher antibacterial activity than the other five medicinal plants against and sp. SMCB-II exhibited higher antioxidant, NO inhibitory, and antibacterial effects than SMCB-I, since , , and were only used for the production of SMCB-II. The SMCBs would be expected to contribute to an easy-to-carry, easy-to-consume, and high value-added health beverage for the modern people.
对九种药用植物及其不同配比的棒状药用浓缩饮料（SMCB - I和SMCB - II）进行了评估，考察其对呼吸系统疾病相关病原菌的抗氧化、一氧化氮（NO）抑制及抗菌作用。在总酚和总黄酮含量较高的[具体植物名称未给出]、[具体植物名称未给出]、[具体植物名称未给出]和[具体植物名称未给出]中，抗氧化活性较高。在[具体植物名称未给出]、[具体植物名称未给出]和[具体植物名称未给出]中，NO抑制活性较高。[具体植物名称未给出]、[具体植物名称未给出]和[具体植物名称未给出]对[具体病原菌名称未给出]和[具体病原菌名称未给出]sp.的抗菌活性高于其他五种药用植物。由于[具体植物名称未给出]、[具体植物名称未给出]和[具体植物名称未给出]仅用于生产SMCB - II，所以SMCB - II表现出比SMCB - I更高的抗氧化、NO抑制及抗菌作用。预计这些SMCBs可为现代人提供一种便于携带、易于饮用且附加值高的健康饮料。
